What is eflornithine?
eflonithine is a drug effective against African trypanosomiasis and excessive hair growth. Experimental studies also indicate that the drug can be used in combined therapy to prevent recurrence of colorectal polyps. Some brands that this drug is sold include Ornidyl® and Vaniqa®. All formulations are only available as prescription.
This medicine was developed at the age of 70. Scientists have noted that Eflornithin interfered with the metabolic processes within the parasites responsible for African trypanosomiasis, also known as a "sleeping disease". When the drug is injected, it kills parasites and is quickly expressed from the body before it has a chance to cause damage inside the body. Like many drugs that were considered effective in the treatment of diseases most commonly found in the developing world, Eforninnin has disappeared for several years without extensive development, because there were concerns that it would not be profitable.
This Copening when it was found that the drug was useful in the treatment of excess or undesirable inLases of the face. Eflornithin affects enzymes involved in new hair growth, slows the speed of hair growth and makes it easier for people to control their face hair. The drug is administered locally twice a day. With the commercial development of Eflornithin creams, they cooperated with humanitarian organizations to prepare injection forms of drugs for the treatment of sleeping disease in Africa.
The side effects of eflornithin vary depending on how the drug is used. Face creams can cause acne, irritation and overgrown hair. Injection forms are associated with fatigue, nausea, diarrhea, bruises, weakness and sore throat. Some people experience more serious side effects, including convulsions and hearing loss. When patients experience side effects, the physician may be consulted on the methods of their management. Serious side effects such as convulsions should be reported because they may require medical treatment.
people using a localEfornithin cream should be aware that the medicine must be evenly massaged after applying in a thin layer to the skin of the face and left to dry completely before applying sunscreen, make -up and other products. It is also important to avoid face washing for at least eight hours after EFORNIN application to reduce the risk of drug washing. Washing the face before applying drugs can help keep the skin clean and open the pores, allowing them to completely absorb the cream. Measures such as shaving and pweeezing will still need to control your face hair.